Thank you for sharing!

Your article was successfully shared with the contacts you provided.
Alex Azar's role as an executive at drugmaker Eli Lilly & Co. has fueled lawmakers’ concerns that he might not be willing to take a tough stance against the pharmaceutical industry on drug prices. (Photo: HHS.gov)

High drug prices are sure to come up again. So is Obamacare.


Join BenefitsPRO

Don’t miss crucial news and insights you need to navigate the shifting employee benefits industry. Join BenefitsPRO.com now!

  • Unlimited access to BenefitsPRO.com - your roadmap to thriving in a disrupted environment
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com
  • Exclusive discounts on BenefitsPRO.com and ALM events.

Already have an account? Sign In Now
Join BenefitsPRO

Copyright © 2019 ALM Media Properties, LLC. All Rights Reserved.